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Original Article
Advancements in the prevention and treatment of dis-
eases as well as novel technologies in biomedicine have 
led modern societies to experience an unprecedented 
increase in life expectancy (United Nations, 2009). As a 
consequence, people are spending a substantial part of 
their lives in older age. There are currently 962 million 
individuals aged 60 years and older worldwide, and 
global projections indicate that this figure will reach 
almost 2.1 billion by 2050 (United Nations, 2017). While 
a longer life is a precious gift, aging comes with distinct 
changes in biopsychosocial markers, leading to multifac-
eted processes of adaptation and increased morbidity and 
mortality. Biological aging is therefore considered as a 
major risk factor for chronic diseases and disabling con-
ditions, causing tremendous societal and economic bur-
den (Barzilai et al., 2018). Although some influential 
pioneering studies have indicated the relevance of psy-
chosocial factors for age-related health changes (Hawkley 
et al., 2006; Johnson et al., 1989; Weng et al., 2000), the 
role played by psychosocial factors regarding the 
age-related increase in morbidity and mortality has not 
yet been sufficiently recognized. Prolonging the health 
span and reducing health-care costs are emerging as cen-
tral goals for modern societies, which can only be 
achieved by investigating the underlying biopsychosocial 
aging processes and identifying novel options to improve 
healthy aging (Beard et al., 2016).
Healthy aging can be defined as “the process of devel-
oping and maintaining the functional ability that enables 
well-being in older age” (World Health Organization, 
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2015). Aging is associated with distinct changes in hor-
mone secretion. Throughout a man’s lifespan, endocrine 
systems undergo specific changes: Activity of the hypo-
thalamic-pituitary-gonadal (HPG) axis decreases with 
age, whereas the hypothalamic-pituitary-adrenal (HPA) 
axis becomes hyperactive with higher age (Ebner et al., 
2014). At around the age of 40 years, the function of the 
Leydig cells in the testes begins to decrease, diminishing 
the levels of sex steroids (Fiacco et al., 2018). Most 
prominently, testosterone (T) decreases, which can poten-
tially lead to a deterioration of physical and mental health 
(Ford et al., 2016). An age-related T decrease has also 
been observed in specifically healthy aging men (Harman 
et al., 2001). While Sartorius et al. (2012) assume that 
very good health may prevent aging men from sex steroid 
decline, there is increasing evidence to support a continu-
ous but decelerated age-related decline in T in healthy 
men (Feldman et al., 2002; Walther et al., 2016). 
Dehydroepiandrosterone (DHEA) and its sulfate 
(DHEAs) have also been identified to decrease in aging 
men due to the attrition of DHEA(s)-producing cells in 
the zona reticularis of the adrenal cortex (Ohlsson et al., 
2010; Parker, et al., 1997). Age trends regarding proges-
terone (P) and estradiol (E2), however, are conflicting, 
with studies reporting that these hormones remain stable 
(Oettel & Mukhopadhyay, 2004; Sartorius et al., 2012), 
increase (Jasuja et al., 2013), or slightly decline (Lewerin 
et al., 2014; Zitzmann et al., 2005). Similarly to the case 
for androgens, good self-reported health has been sug-
gested to buffer the potential age-related changes in P and 
E2 (Sartorius et al., 2012; Walther et al., 2016). Contrary 
to the suggested decline in sex steroids, cortisol (C) 
increases with age (Karlamangla et al., 2013). This is due 
on the one hand to changes in the number of mineralocor-
ticoid and glucocorticoid receptors and a change in sensi-
tivity of the negative feedback mechanisms of the HPA 
axis (Gupta & Morley, 2014) and on the other hand to an 
age-related increased number of corticotropin-releasing 
hormone (CRH) neurons and subsequently in CRH secre-
tion, further increasing cortisol output of the HPA axis 
(Zhou & Swaab, 1999). Age-related changes in the endo-
crine system also harbor the risk of physical or psycho-
logical pathologies, if mechanisms of adaptation fail to 
buffer these changes.
Parallel to endocrine changes, psychosocial adapta-
tions can also be observed during aging. Subjective health 
seems to be an important indicator of healthy aging (Han 
et al., 2015). Symptoms of aging in males, such as 
decreased potency, muscular strength, or energy, are 
exhibited naturally with higher age (Jakiel et al., 2015). 
Large population-based cohort studies have also demon-
strated a decline in general mental health with age 
(Norman et al., 2009; Payne et al., 2014). This associa-
tion is potentially strongly influenced by physical illness 
and its consequences (Lorem et al., 2017). Sexual func-
tion, as part of overall quality of life, decreases in aging 
men (Giovanni Corona et al., 2013; Walther et al., 2017). 
For instance, 61% of 40–69-year-old males have experi-
enced erectile dysfunction at least once in their life, 
whereas this rate increases to 77% among ≥ 70-year-olds 
(Wagle et al., 2012). Psychological factors such as self-
esteem and social support also undergo changes with age. 
With regard to self-esteem, the findings are conflicting, 
with some studies reporting that males’ self-esteem 
increases until their sixties and subsequently declines 
(Orth et al., 2015; Robins et al., 2002) and other studies 
indicating a relative stability until close to death (Wagner 
et al., 2015). Social support is an important resource 
associated with health, with findings suggesting that age-
related changes in social networks occur voluntarily and 
that social support increases with age (Charles & 
Carstensen, 2009). Aging can also foster loneliness 
(Hawkley & Kocherginsky, 2018), which is associated 
with several negative health outcomes (Shankar et al., 
2017; Tian, 2016) and increased mortality (Harris et al., 
2015). Taken together, subjective good health is associ-
ated with healthy aging, aging symptoms, such as 
decreased potency, increase and sexual function decreases 
with higher age. Results on self-esteem are conflicting, 
showing either a decline or stability, while social support 
can be beneficial for health, and loneliness—the opposite 
of social support—can foster negative effects on health.
Endocrine parameters are emerging as promising 
markers for the continuous monitoring of healthy aging 
since changes in androgens and estrogens were reported 
to be predictive for all-cause and cause-specific mortality 
in men (Hsu et al., 2016). Psychosocial measures, on the 
other hand, have also been identified to predict the aging 
process (e.g., Dainese et al., 2011). Isolated views on 
either psychosocial or endocrine factors alone neglect the 
complex interactions between the two domains and 
potentially impede the investigation of healthy aging as a 
whole. An integrative biopsychosocial approach as first 
described by George and Engel (1980) could be benefi-
cial, especially within the employed multidimensional 
framework of healthy aging.
According to the biopsychosocial model, endocrine 
markers and psychosocial measures potentially influence 
each other. For symptoms of aging in men, the literature 
identified more symptoms of aging in the case of lower T 
secretion (Handelsman et al., 2015). Low T secretion is 
also associated with a higher risk of age-related illnesses 
such as dementia (Ford et al., 2018). A cross-sectional 
study with specifically healthy aging men failed to link 
subjective health to T secretion (Dunbar et al., 2001). 
Lower T secretion can further elevate symptoms of sex-
ual dysfunction in men (Corona et al., 2009) or moderate 
the association between age and sexual dysfunction 
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(Walther et al., 2017). Findings regarding endocrine asso-
ciations with psychosocial measures such as self-esteem 
and social support are scarce. A lack of social support has 
previously been associated with flatter diurnal C slopes 
(Friedman et al., 2012; Gaffey et al., 2016), while self-
esteem has either been associated with increased morning 
C (Zorrilla et al., 1995) or has shown no direct associa-
tion with C (Pruessner et al., 1999), although the latter 
study investigated stress-related C secretion while the 
former investigated basal C secretion. An influential 
review revealed that various further studies did not iden-
tify links between endocrine secretion and psychosocial 
measures (Campbell & Ehlert, 2012), thus underlining 
the need to further investigate these associations and 
highlighting the importance of assessing changes in both 
psychosocial measures and endocrine markers.
To the knowledge of the authors, no previous study 
has investigated aging in specifically healthy men 
employing a wide range of biological, psychological, and 
social measures in a longitudinal design. The study aims 
to investigate how endocrine markers and psychosocial 
measures develop in the distinct population of healthy 
aging men over a time span of 4 years. The first hypoth-
esis is that T and DHEAs would decrease with age, while 
C would increase, and E2 and P would remain stable. The 
second hypothesis is that health-related measures would 
decline, while self-esteem and social support would 
remain stable. The last hypothesis expects to find a buff-
ering effect of self-esteem and social support on endo-
crine markers and that endocrine secretion would 
influence the development of all psychosocial measures 
since the literature suggests that endocrine development 
and psychosocial changes influence one another.
Materials and Methods
Participants
A total of 98 healthy men aged 40 years and over from the 
Men’s Health 40+ study (Walther et al., 2016) were 
investigated using a longitudinal design. At the beginning 
of the investigation, participants were aged between 40 
and 75 years. An inclusion criterion for both time points 
of the study was a subjective health rating of “good”, 
“very good,” or “excellent” to enable a specific investiga-
tion of healthy individuals. This was assessed through the 
first question of the Short Form 36 Health Survey (SF-36, 
Bullinger et al., 1995), “How would you describe your 
current health condition?”, with response options ranging 
from “very bad” to “excellent”. Participants with self-
reported acute and chronic medical conditions, psychiat-
ric disorders, psychopharmacological treatment, or 
psychotherapy were screened out and all participants had 
to be fluent in German. The study was approved by the 
ethics committee of the Canton of Zurich in Switzerland. 
All participants accepted the terms of the study and gave 
their written informed consent.
Procedure
The study comprised a baseline measurement and a fol-
low-up conducted 4 years after the initial investigation. 
At both time points, participants first underwent a screen-
ing to test whether all inclusion criteria were met. After 
being accepted for the study, participants subsequently 
completed three psychometric test batteries (in German), 
which consisted of various validated self-rating question-
naires. Each test battery required approximately 60 min 
to complete. Participants underwent a biological exami-
nation in the laboratory, during which various physiologi-
cal (e.g., body composition) and endocrine parameters 
were obtained by trained study personnel between 8:00 
and 8:15 am. Participants were instructed not to eat, 
drink, or consume cigarettes for 2 hr before the laboratory 
examination. They were asked to refrain from physical or 
sexual activity for 24 hr before the examination and alco-
hol or caffeine consumption for 48 hr before sampling 
(Stalder et al., 2016). Contaminated saliva samples (e.g., 
through prior coffee consumption or eating) produced 
missing values and could not be analyzed. In general, 
saliva samples, if collected under controlled conditions, 
are a reliable, noninvasive alternative to serum samples 
and have shown to be applicable for the analysis of ste-
roid hormones (Gröschl, 2017). Detailed descriptions of 
the biological examination are described elsewhere 
(Walther et al., 2016).
Psychosocial Measures
Health-Related Quality of Life. To assess health-related 
quality of life, the Short Form 36 Health Survey (SF-36; 
Bullinger et al., 1995) and the more specific Aging 
Males’ Symptoms rating scale (AMS; Zimmermann 
et al., 1999) were used. The SF-36 is a 36-item self-report 
questionnaire which provides sum scores for eight sub-
scales and two general scales. The general scale “physical 
health” was used in the present study. It has been used in 
multiple studies in a variety of fields over the last decades 
and is a well-established instrument for the assessment of 
health-related quality of life. Internal consistency for the 
present sample was α = .63.
The Aging Males’ Symptoms rating scale consists of a 
general sum score, which was used in the present study, 
and three distinct subscales. Participants rated the 17 
symptom-related items in terms of severity from “no” to 
“very severe”. This questionnaire was specifically 
designed to assess male-specific symptoms of aging and 
thus to measure health-related quality of life for this 
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population. It is a widely used and well-documented 
instrument within male-specific aging studies. Cronbach’s 
alpha for the current sample was α = .84.
Sexual Function. The German version of the Interna-
tional Index of Erectile Function (IIEF; Rosen, 1997; 
Wiltink et al., 2003) was used to measure erectile func-
tion with 15 items. The proposed German scoring was 
used for the present analyses. The IIEF consists of sum 
scores, including two distinct subscales: sexual func-
tion, which was used here, and sexual desire (Wiltink 
et al., 2003). The IIEF is a self-report measurement tool 
which is well-validated and widely used in clinical as 
well as epidemiological studies. Cronbach’s alpha for 
this sample was α = .64.
Mental Health. The Brief Symptom Inventory 18 (BSI-
18) is a well-established 18-item self-report question-
naire measuring mental health on three subscales and a 
general sum scale, which was used in the present study 
(Spitzer et al., 2011). The BSI-18 is a time-efficient 
measurement tool which is widely used. The BSI-18 is 
a shortened version of the Brief Symptom Inventory 
(Franke & Derogatis, 2000). The questionnaire showed 
good internal consistency (α = .83) in the present 
sample.
Self-Esteem. The Multidimensional Self-Esteem Scale 
(MSWS; Schütz & Sellin, 2006) was used to assess self-
esteem as a multidimensional construct. It investigates 
self-esteem as a trait. The questionnaire consists of 32 
items which form a hierarchical structure of subscales, 
with two scales representing distinct factors for general 
self-esteem (used in the present study) and body-related 
self-esteem. Cronbach’s alpha for the current sample 
was α = .89.
Social Support. The Berlin Social Support Scale (BSS; 
Schwarzer & Schulz, 2003) is a well-established instru-
ment to measure social support. The questionnaire con-
sists of four subscales and a general score, which was 
used in this study. Internal consistency was α = .90 in the 
present sample.
Hormone Analyses
Saliva samples were obtained between 8:00 and 8:15 
am under standardized laboratory conditions using 
SaliCaps (SaliCaps, IBL International GmbH, 
Hamburg, Germany). Samples were immediately 
stored at −20°C until required for biochemical analy-
sis. Enzyme-linked immunoassays were used to ana-
lyze C, DHEAs, and P, while T and E2 were analyzed 
using luminescence immunoassay (Chiappin et al., 
2007; Goncharov et al., 2006). All hormones were 
analyzed at the Biochemical Laboratory at the 
Institute of Psychology of the University of Zurich. 
The intra- and interassay variation was less than 
10%, while sensitivity was 0.003 μg/dl for C, 1.8 pg/
ml for T, 1.5pg/ml for DHEAs, 0.3 pg/ml for E2, and 
2.6 pg/ml for P.
Statistical Analysis
Bootstrapped zero-order and partial Pearson correla-
tions were conducted to examine direct cross-sectional 
and longitudinal associations between baseline and 
follow-up measures (detailed information is provided 
in the supplemental material). Partial correlations were 
controlled for physical activity, income, educational 
level, fat mass, and age to control for any potential 
bias. To examine changes in endocrine and psychoso-
cial factors over time, a linear mixed-model approach 
with random intercepts was used, which enables a 
more specific analysis of the longitudinal effects than 
simple correlation and regression analyses. Visual 
inspection for normality of the residuals was per-
formed for every single model; if normality of the 
residuals was violated, the respective variable was log-
transformed (Sollberger & Ehlert, 2016). Linear mixed 
models were calculated in R (Version 3.4.3) using the 
package “lme4” (Bates et al., 2015). The analysis was 
conducted in two subsequent steps: first, a more gen-
eral analysis of the change over time and second the 
specific moderation analyses. Within the first step, the 
dependent variables were the respective hormones or 
psychosocial measures, with the time variable as an 
independent fixed effect variable, displaying intraindi-
vidual changes between the two measurement time 
points. Within the current set of hypotheses, random 
effects (i.e., whether there are differences between the 
participants) are no priority in the current set of 
hypotheses and thus will not be reported or discussed 
in detail. All calculations were controlled for physical 
activity, educational level, and income. Endocrine and 
health-related measures were further controlled for fat 
mass. The aforementioned moderation analyses were 
conducted with not only the baseline values but the 
longitudinal data for both the dependent variables and 
the moderators, which enabled us to, additionally, 
investigate the changes in these variables. The model 
for the moderation analyses consisted of the respective 
dependent variable and as predictors, the time* 
moderator term as well as the covariates were included. 
For all mixed-model analyses, participants’ endocrine 
sampling adherence was included in the models, but 
none of the parameters were significant predictors and 
did not change the general results. To apply the 
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principle of parsimony, they were therefore not 
included in the final analyses.
Moderation analysis was conducted for the influence 
of social support and self-esteem on endocrine markers 
and for the influence of all endocrine markers sepa-
rately on the psychosocial markers. All calculations, 
again, were controlled for physical activity, educational 
level, and income. Endocrine and health-related mea-
sures were further controlled for fat mass. The Akaike 
information criterion (AIC) was used to assess model 
quality for the change over time, as well as the modera-
tion analyses. For all calculations within this study, the 
Benjamini–Hochberg procedure was applied to the p 




Out of 271 participants from the baseline assessment, 130 
(48%) completed the screening and 98 (36%) attended 
the follow-up assessment (Figure 1). The participants 
were initially informed that they would be participating 
in a cross-sectional study. Three years after the baseline 
assessment, participants were asked whether they would 
like to participate in a follow-up assessment. Twenty-two 
(8%) of the 271 participants had an invalid e-mail address 
and 60 (22%) did not respond to repeated e-mails. Out of 
the 130 participants who completed the screening, 15 
(12%) were no longer eligible to participate due to physi-
cal illnesses and 17 (13%) were no longer interested in 
participating. Finally, 98 (75%) participants participated 
in the follow-up assessment, 97 (99%) of whom com-
pleted the laboratory assessment.
Descriptive data of these 97 participants are presented 
in Table 1. Participants’ mean age was 61.26 years (SD = 
10.02) at baseline and 65.18 (SD = 9.98) at follow-up. 
Most participants were in a relationship (N = 8, 8.25%) 
or married (N = 70, 72.16%) throughout the complete 
study. The largest proportion of participants had a univer-
sity degree and an annual income between 50,000 and 
150,000 Swiss Francs. A total of 84.54% (N = 82) 
reported being nonsmokers at baseline and 86.46% (N = 
83) at follow-up. Around 60% (N = 59) of the partici-
pants did not take any medication at baseline, while 53% 
(N = 51) were medication-free at follow-up. 
Antihypertensives were the most commonly taken medi-
cation type (46% for both time points, N = 23/28), fol-
lowed by the category “Other”, which mostly comprised 
cholesterol medication and bowel-regulating medica-
tions. The largest proportion of participants (Baseline: N 
= 40,41%; Follow-up: N = 51, 53%) reported undertak-
ing 4–6 hr of physical activity per weeks.
Analyses comparing differences between the partici-
pants who participated at both time points and those who 
only participated at the first time point showed that the 
former were older and healthier overall, thus supporting 
the aim to investigate participants who were able to main-
tain their health. There were no significant differences in 
endocrine measures between participants of T1+T2 and 
only T1, with the exception of P, which was significantly 
lower for participants who did not return. Further analy-
ses comparing eligible and ineligible participants who 
returned at the second time point showed that the eligible 
participants were indeed healthier, although they reported 
higher values with regard to pain. Overall, the aim to 
investigate healthy participants was supported (detailed 
information in the supplemental materials). Correlations 
between all parameters can be found in the supplemental 
materials.
Changes Over Time
Changes over time for endocrine markers and psychoso-
cial measures are displayed in Figure 2. Linear mixed-
model analyses with random intercepts yielded significant 
changes over time (Table 2). Longitudinal effects for 
endocrine secretion showed significant decreases in T 
(b = −0.3, p < .001, −3.07% per year) and DHEAs (b = 
−0.47, p < .001, −12.18% per year). Furthermore, C (b = 
0.44, p =.01, 7.36% per year) and P (b = 02, p = .001, 
5.96% per year) increased, while E2 (b = 0.07, p = .623, 
2.51% per year) did not change significantly. It was 
decided to interpret the change in C despite a slightly 
worse model fit because the covariates were entered in a 
theory-based manner. After excluding educational level, 
which was not a significant predictor of C, the model fit 
improved.
Figure 1. Flow Chart of Participant Participation
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Table 1. Sample Characteristics.
Baseline Follow-up
 N M/Freq. SD/% N M/Freq. SD/%
Age 97 61.26 10.02 97 65.18 9.98
Fat mass in percent (%) 95 22.42 5.43 97 20.58 7.03
C (nmol/L) 95 4.77 8.99 97 6.76 9.28
T (pg/ml) 93 42.53 18.44 96 37.88 26.28
DHEAs (ng/ml) 95 1.95 1.31 97 1.31 1.06
E2 (pg/ml) 94 1.46 1.06 97 1.63 1.69
P (pg/ml) 94 34.29 13.04 97 45.03 36.08
AMS—main score 89 26.22 6.93 94 26.74 6.68
SF-36—physical health 97 65.47 3.93 96 65.36 4.09
BSI—main score 97 22.43 5.28 94 21.90 3.74
IIEF—sexual function 96 28.61 6.98 94 28.10 6.73
MSWS—main score 96 179.80 20.68 94 180.21 19.89
BSSS—main score 96 3.44 0.51 94 3.52 0.43
Marital status (%) 97 96  
Single 8 8.25 5 5.21
In relationship 8 8.25 10 10.42
Married 70 72.16 70 72.92
Divorced 10 10.31 10 10.42
Widowed 1 1.03 1 1.04
Education (%) 97 96  
Lower-track secondary school 8 8.25 9 9.38
Medium-track secondary school 23 23.7 23 23.96
Higher-tracker secondary school 7 7.22 7 7.29
University degree 43 44.33 46 47.92
Other 16 16.49 11 11.46
Income (in CHF, %) 97 96  
No income 1 1.03 1 1.04
Up to 30,000 3 3.09 3 3.13
30,001–50,000 7 7.22 4 4.17
50,001–100,000 35 36.08 38 39.58
100,001–150,000 35 36.08 38 39.58
150,001–200,000 12 12.37 7 7.29
More than 200,000 4 4.12 5 5.21
Number of children (%) 97 96  
0 20 20.62 19 19.79
1 14 14.43 15 15.63
2 42 43.30 40 41.67
3 18 18.56 18 18.75
4 2 2.06 3 3.13
5 or more 1 1.03 1 1.04
Smoking (%) 97 96  
Nonsmoking 82 84.54 83 86.46
Smoking 15 15.46 13 13.54
Medication (%) 97 96  
No 59 60.08 51 53.13
Yes 38 39.18 45 46.88
Type of medicationa (%) 38 45  
Antihypertensives 23 45.09 28 45.16
Vitamins and minerals 1 1.96 5 8.06
(continude)
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Figure 2. Changes Over Time for Endocrine Markers and Psychosocial Measures. (A) Shows the changes over time for 
endocrine measures. DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol. Changes on percent scale with higher values are 
shown as 100%. (B) Shows the change over time of psychosocial measures. Scale shows percent of maximum achievable value on 
respective questionnaire scale. For mean and SD see Table 2. 
Baseline Follow-up
 N M/Freq. SD/% N M/Freq. SD/%
Other 27 52.94 29 46.77
Physical activity (%) 97 96  
Less than 1 hr 1 1.03 1 1.04
1–3 hr 32 32.99 20 20.83
4–6 hr 40 41.24 51 53.13
7 hr or more 24 24.74 24 25.00
aParticipants could indicate more than one medication.
Note. N = number of participants; M = mean; Freq. = frequency; SD = standard deviation; % = percent; C = cortisol; T = testosterone; 
DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol; P = progesterone; AMS = Aging Males’ Symptoms scale; SF-36 = Short-Form 36; 
BSI = brief symptom inventory; IIEF = International Index of Erectile Function; MSWS = Multidimensional Self-Esteem Scale; BSSS = Berlin 
Social Support Scale; CHF = Swiss Francs.
Table 1. (continued)
The results for the psychosocial measures show no 
significant changes in male aging symptoms (b = 
0.03, p = .190), physical health (b = −0.32, p = .506), 
mental health (b = −0.04, p = .623), sexual function (b = 
−0.91, p = .368), and self-esteem (b = −0.6, p = .682). 
Social support significantly increased over time 
(b = 0.09, p = .042). Similarly to C, the change in 
social support was interpreted despite slightly worse 
model fit, since covariates were selected in a theory-
based manner.
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Moderation Analyses
Results of the moderation analyses showed that by trend, 
social support moderated the age-related change in C (b 
= 0.544, p = .087) and in DHEAs (b = 0.010, p = .079). 
As a further trend, C (b = 0.198, p = .055) and T (b = 
1.410, p = .054) moderated the change in sexual function 
over time. Social support was found to significantly mod-
erate the change in C over time (b = 0.013, p = .012), 
insofar as higher social support was associated with lower 
C secretion. This finding did not remain significant after 
adjusting for the false discovery rate (Table 3). In conclu-
sion, no significant moderation effects were identified.
Discussion
In the present study examining 97 healthy men at base-
line and 4-year follow-up, an age-related decrease in T 
and DHEAs and an increase in P and C was identified. 
No significant change in E2 was detected within this 
period of time. Scores on all health-related psychoso-
cial measures such as self-reported health, mental 
health, self-esteem, and sexual function remained sta-
ble, while social support increased. No moderation 
effects of longitudinal self-esteem scores and social 
support on endocrine changes were found, and there 
were no moderation effects of endocrine markers on 
psychosocial measures. Therefore, in the healthy aging 
men examined, age-related changes in endocrine mark-
ers did not match changes in psychosocial measures. 
These findings reveal that despite age-related changes 
in hormones, it is still possible to maintain or even 
increase a high quality of life, mental health, sexual 
function, self-esteem, and social support.
The results for endocrine measures are mostly in line 
with the literature. An increase in C and a decrease in T 
and DHEAs, as previously reported by other studies 
(Ford et al., 2016; Gupta & Morley, 2014) was identified. 
Findings for E2 are also in accordance with previous 
studies, which showed either stability or a slight decrease, 
as described in a detailed review by Fiacco et al. (2018). 
However, the increase in P in the present study is in con-
trast to previous research demonstrating either stability or 
a decline with age (Oettel & Mukhopadhyay, 2004). As P 
is synthesized not only in the Leydig cells, which decrease 
in function with age, but also in the adrenal glands, which 
are also crucial for male secretion of P (Oettel & 
Mukhopadhyay, 2004; Schumacher et al., 2014), the 
adrenal glands might attempt to compensate for the 
reduced Leydig cell function by producing more P. This 
could explain the increase in P despite the decline in T, 
which is also synthesized in the testes.
Interestingly, health-related measures remained stable 
in the present study, which is yet to be discussed. Various 
studies reported that different aspects of quality of life 
such as mental health (e.g., Payne et al., 2014) or sexual 
function (Corona et al., 2013) decreased with age while 
symptoms of aging increased (Jakiel et al., 2015). 
Previous studies predominantly investigated general or 
clinical populations rather than specifically healthy indi-
viduals as in the present study. The current findings there-
fore add valuable insights into the healthy aging process. 
Moreover, the present results give rise to the question of 
whether the decrease in psychosocial parameters is natu-
ral or whether it is due to physical illnesses. The latter 
was also proposed by Lorem et al. (2017), and is further 
supported by the stability of subjective physical health in 
this sample of healthy aging men.
Table 2. Linear Mixed Model Results Over Time.
AIC0 AIC Estimate SEb p pcorr 95% CIlower 95% CIupper
C 573.9 579.7 0.44 0.15 0.003 0.01 0.144 1.114
T 375.9 370.4 −0.3 0.08 < .001 < .001 −0.457 −0.147
DHEAs 409.6 358.7 −0.47 0.05 < .001 < .001 −0.587 −0.36
E2 433.6 447.5 0.07 0.09 0.413 0.623 −1.102 0.247
P 189.1 187.6 0.2 0.05 < .001 0.001 0.1 0.302
AMS −59 −51.9 0.03 0.02 0.104 0.19 −0.006 0.067
SF-36 1042 1050.3 −0.32 0.38 0.403 0.506 −1.081 0.431
BSI 1116.3 1122.4 −0.04 0.55 0.47 0.623 −1.5 0.7
IIEF 1254 1258.4 −0.91 0.76 0.234 0.368 −2.411 0.595
MSWS 1608.5 1621.1 −0.6 1.45 0.682 0.682 −2.85 3.06
BSSS 193.4 206.1 0.09 0.04 0.019 0.042 0.015 0.16
Note. N = 97; AIC0 = Akaike information criterion of the null model; AIC = Akaike information criterion; SE = standard error; p = p value; 
pcorr = corrected p value; CI = confidence interval; C = cortisol; T = testosterone; DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol; 
P = progesterone; AMS = Aging Males’ Symptoms scale; SF-36 = Short-Form 36; BSI = brief symptom inventory; IIEF = International Index 
of Erectile Function; MSWS = Multidimensional Self-Esteem Scale; BSSS = Berlin Social Support Scale. All calculations controlled for physical 
activity, educational level, and income; endocrine and health-related measures further controlled for fat mass.
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The finding of maintained self-esteem in healthy aging 
men is partially in line with the literature, which reported 
that self-esteem increases until the age of around 60 and 
then shows a steady but slow decline until old age (Orth 
et al., 2010, 2012). Another recent study reported that 
self-esteem remains stable until very old age and only 
declines shortly before death (Wagner et al., 2015). An 
explanation for the current findings of this study might lie 
in the specific sampling of healthy participants, because 
as Wagner et al. (2015) stated, low subjective health and 
its potential constraints are important factors that nega-
tively influence self-esteem. Furthermore, a high 
Table 3. Linear Mixed Model Results for All Moderation Analyses.
AIC0 AIC Estimate SE p pcorr 95% CIlower 95% CIupper
MSWS*C 573.9 577.1 0.002 0.007 0.736 0.897 −0.012 0.017
BSSS*C 573.9 573.9 0.544 0.316 0.087† 0.696 −0.078 1.165
MSWS*T 375.9 346.5 −0.003 0.004 0.346 0.865 −0.011 0.004
BSSS*T 375.9 342.2 0.214 0.164 0.195 0.865 −0.114 0.537
MSWS*DHEAs 409.6 359.7 0.001 0.003 0.791 0.897 −0.007 0.005
BSSS*DHEAs 409.6 359.7 0.010 0.126 0.079† 0.696 −0.239 0.260
MSWS*E2 433.6 445.8 0.001 0.004 0.323 0.865 −0.007 0.010
BSSS*E2 433.6 443.8 −0.112 0.191 0.559 0.897 −0.489 0.267
MSWS*P 189.1 185.0 −0.001 0.003 0.665 0.897 −0.006 0.004
MSWS*P 189.1 187.6 0.013 0.111 0.908 0.908 −0.230 0.198
C*SF36 1042 1053.3 0.051 0.051 0.319 0.865 −0.049 0.152
T*SF36 1042 1037.0 −0.020 0.021 0.333 0.865 −0.062 0.021
DHEAs*SF36 1042 1051.2 −0.261 0.337 0.440 0.880 −0.926 0.401
E2*SF36 1042 1049.7 0.100 0.339 0.291 0.865 −0.571 0.769
P*SF36 1042 1045.0 −0.039 0.026 0.134 0.865 −0.091 0.012
C*AMS −59 −48.9 0.002 0.002 0.341 0.865 −0.003 0.007
T*AMS −59 −45.9 0.002 0.001 0.884 0.908 −0.002 0.002
DHEAs*AMS −59 −48.4 −0.011 0.016 0.525 0.897 −0.043 0.022
E2*AMS −59 −46.2 0.004 0.018 0.803 0.897 −0.030 0.039
P*AMS −59 −46.6 0.0004 0.001 0.748 0.897 −0.002 0.003
C*BSI 1116.3 1125.8 −0.036 0.069 0.602 0.897 −0.172 0.010
T*BSI 1116.3 1111.5 −0.011 0.029 0.704 0.897 −0.068 0.046
DHEAs*BSI 1116.3 1125.0 −0.519 0.489 0.291 0.865 −1.485 0.448
E2*BSI 1116.3 1119.5 0.673 0.470 0.154 0.865 −0.256 1.600
P*BSI 1116.3 1119.4 −0.019 0.035 0.580 0.897 −0.089 0.511
C*IIEF 1254 1284.8 0.198 0.102 0.055† 0.696 −0.007 0.399
T*IIEF 1254 1267.4 0.030 0.042 0.481 0.897 −0.054 0.114
DHEAs*IIEF 1254 1287.0 1.410 0.723 0.054† 0.696 −0.026 2.835
E2*IIEF 1254 1284.0 0.174 0.715 0.807 0.897 −1.274 1.590
P*IIEF 1254 1282.5 0.011 0.054 0.839 0.907 −0.096 0.117
C*MSWS 1608.5 1616.8 0.062 0.205 0.762 0.897 −0.341 0.472
T*MSWS 1608.5 1595.3 −0.072 0.084 0.400 0.872 −0.241 0.094
DHEAs*MSWS 1608.5 1617.8 −0.551 1361 0.686 0.897 −3.234 2.160
E2*MSWS 1608.5 1610.1 0.162 1.362 0.906 0.908 −2.525 2.867
P*MSWS 1608.5 1610.1 −0.089 0.109 0.414 0.872 −0.306 0.126
C*BSSS 193.4 204.1 0.013 0.005 0.012* 0.480 0.003 0.023
T*BSSS 193.4 205.4 −0.001 0.002 0.657 0.897 −0.005 0.003
DHEAs*BSSS 193.4 208.5 0.046 0.034 0.176 0.865 −0.021 0.113
E2*BSSS 193.4 207.7 0.028 0.034 0.412 0.872 −0.039 0.095
P*BSSS 193.4 208.2 −−0.001 0.003 0.627 0.897 −0.007 0.004
Note. N = 97; AIC0 = Akaike information criterion of the null model; AIC = Akaike information criterion; SE = standard error; p = p value; 
pcorr = corrected p value; CI = confidence interval; C = cortisol; T = testosterone; DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol; 
P = progesterone; SF36 = Short-Form 36; AMS = Aging Males’ Symptoms scale; BSI = brief symptom inventory; IIEF = International Index 
of Erectile Function; MSWS = Multidimensional Self-esteem Scale; BSSS = Berlin Social Support Scale. All calculations controlled for physical 
activity, educational level, and income; endocrine and health-related measures further controlled for fat mass.
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educational level increases self-esteem (Orth et al., 
2012), which is relevant since 44.33% of this sample had 
a university degree.
This healthy aging sample reported increasing levels 
of social support over time. Due to the lack of studies 
specifically investigating subjective social support over 
the lifespan, and given the heterogeneity of methods used 
to assess social support, integrating the findings into the 
existing literature is challenging. As older individuals 
play an active role in designing their social networks 
(Charles & Carstensen, 2009), the significant increase 
found in the present study might indicate that healthy 
aging men indeed actively manage their social networks. 
It is crucial to mention that the size of the social networks 
themselves was not assessed, but rather measured subjec-
tive, self-rated social support using a validated question-
naire. It cannot reliably be concluded that the social 
network itself changed, although a change in the subjec-
tive perception of social support can be concluded. Scholz 
et al. (2012) further reported that for older individuals, 
social support was associated with higher (emotional) 
well-being.
The current study showed that age-related endocrine 
changes and changes in psychosocial measures are inde-
pendent in healthy aging men. Three potential explana-
tions for this can be suggested: First, most previous 
studies investigated general populations or participants 
with illnesses. In this respect, it is important to discuss by 
way of example that the decline in T did not have any 
effects on mental health in this study, in contrast to a pre-
vious study in a randomly selected sample and therefore 
also including individuals with disorders or potentially in 
a premorbid state (Ford et al., 2016). This premorbid 
state might have led to biological changes prior to the 
manifestation of the respective illness, which were not 
present in this healthy sample. Another study with sub-
jectively healthy aging men further failed to link T to sub-
jective health, although the analyses were cross-sectional 
(Dunbar et al., 2001). Second, there may be a dissociation 
between physiological and psychological measures in 
healthy aging men, as discussed for psychoendocrine 
research in general by Campbell and Ehlert (2012). Third, 
the associations might have been influenced by a poten-
tial confounding variable that was not assessed, as also 
proposed by Campbell and Ehlert (2012). Nevertheless, 
associations between endocrine markers and social sup-
port (Friedman et al., 2012) have previously been 
observed in the general population, whereas the literature 
on the associations between self-esteem and endocrine 
markers remains conflicting (Pruessner et al., 1999; 
Zorrilla et al., 1995).
Some limitations of the present study need to be noted, 
the strongest of which is the aforementioned high dropout 
rate. This was mostly due to the fact that information 
about the follow-up was only provided 3 years after the 
baseline. It is further important to note that compared to 
other European countries, residents of Switzerland have a 
rather high income and level of education (BfS, 2015), 
which limits the ability to generalize the findings to other 
countries. Income and educational level were added as 
covariates in all calculations. The study design did not 
include an unhealthy group, rendering direct comparisons 
impossible and thus limiting potential conclusions 
beyond healthy aging populations. To increase the valid-
ity and reliability, it can be beneficial to employ a design 
with more than one hormone sample for each time point. 
Reliable and valid results can also be obtained with single 
or two-time measurements while controlling for sam-
pling time and presample behavior, as also applied within 
the current study (Barrett-Connor et al., 1999; Clifton 
et al., 2016; Feldman et al., 2002). Similarly, the assess-
ment of more than two time points within the 4 years of 
the study duration, or even expanding the study with a 
study design of more than 4 years would increase the 
potential conclusions that could be derived. Finally, for 
the questionnaires on sexual function and subjective 
health-related quality of life, internal consistency was 
rather low, possibly because most questionnaires were 
predominantly developed to measure dysfunctions in 
nonhealthy populations. Accordingly, they may have 
been less applicable to healthy participants, therefore 
decreasing the reliability for this population.
Nevertheless, the present study also entailed several 
strengths. First, a sample which was able maintain their 
health between the two time points was investigated. 
Second, the use of longitudinal data enabled a more 
detailed investigation of age-related changes compared to 
cross-sectional data. Further strengths of the study 
include the use of validated questionnaires, strict inclu-
sion criteria, and standardized procedures for endocrine 
measurements and for the overall study procedure.
Future studies should incorporate more data (e.g., 
experience sampling and more time points) and include a 
nonhealthy group within a larger overall sample. To 
enable reliable use in healthy aging participants, it would 
be beneficial to develop health-focused rather than ill-
ness-focused questionnaires.
Conclusion
In this sample of healthy aging men, levels of psychoso-
cial measures were maintained despite age-related endo-
crine changes. These age-related endocrine changes were 
not associated with changes in psychosocial measures or 
vice versa. While C and P increased, DHEAs and T 
decreased, and E2 remained stable. In terms of psychoso-
cial measures, levels of subjective health, sexual func-
tion, mental health, self-esteem, and social support were 
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maintained or even increased, despite the age-related 
endocrine changes. These findings are of crucial interest 
for the public. Since more people are experiencing better 
health with higher age, the current finding that endocrine 
changes are independent of psychosocial changes is 
encouraging. It is therefore important to continue to inte-
grate biological and psychosocial parameters into defini-
tions of healthy aging and to take into account the 
potential independence of their developmental course in 
(healthy) aging. As a novel area of research, studies could 
aim to investigate the potential for maintaining high lev-
els of protective psychosocial factors to help prolong 
general health into old age.
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